There were 784 press releases posted in the last 24 hours and 203,406 in the last 365 days.

Insulin Drugs Market 2022 - Opportunities And Strategies – Forecast To 2031

The Business Research Company’s Insulin Drugs Market 2022 - Opportunities And Strategies – Global Forecast To 2031

LONDON, GREATER LONDON , UK, July 14, 2022 /EINPresswire.com/ -- Companies are investing in technologies such as artificial intelligence (AI), smart-device integration, and the usage of 3D-printed organs for the development of insulin drugs which is predicted to be one of the key insulin drugs market trends. Adoption of advanced technologies saves time, reduces research and development costs and shapes the insulin drugs market outlook. AI is being used by pharmaceutical companies to read and review scientific articles, summarize them, and analyze large sets of chemical and biological data to identify better drugs dosage. For example, Sanofi, a French pharmaceutical company, uses AI to automate medical literature reviews on type 2 diabetes. With the help of AI, the company reduced the review time from 13 minutes per paper to around one second per paper.

Rising numbers of diabetic cases will continue to be a driver of this market during the forecast period. According to the International Diabetes Federation (IDF), in 2021, 537 million adults aged in between 20-79 are living with diabetes (1 in 10 are suffering with diabetes) and this number is expected to reach about 643 million by 2030 and 783 million by 2045. Thus, the need for insulin drugs is set to rise steadily during the forecast period. In emerging countries such as India, around 77 million people are diabetic, and this number is expected to rise to 134 million by 2045. In China, by 2045, it is predicted that 174 million people will be diagnosed with diabetes.

Read more on the Global Insulin Drugs Market Report https://www.thebusinessresearchcompany.com/report/insulin-drugs-market

The global insulin drugs market size is expected to grow from $28.95 billion in 2021 to $39.37 billion in 2026 at a rate of 6.3%. The global insulin drugs market share is then expected to grow at a CAGR of 5.7% from 2026 and reach $51.97 billion in 2031.

Major players covered in the global insulin drugs industry are Bioton, Wockhardt Ltd., Julphar, Tonghua Dongbao Pharmaceutical, AstraZeneca.

TBRC’s insulin drugs market report is segmented by product type into basal or long-acting insulins, bolus or fast-acting insulins, pre-mixed insulins, intermediate and short acting insulins, by source type into insulin analogs, human insulin, by application into type 2 diabetes, type 1 diabetes, gestational diabetes, by drug classification into branded drugs, generic drugs, by distribution channel into hospital pharmacies, retail pharmacies, online.

Insulin Drugs Market 2022 – By Product Type (Basal Or Long-Acting Insulins, Bolus Or Fast-Acting Insulins, Pre-Mixed, And Intermediate And Short Acting Insulins), By Source Type (Insulin Analogs, Human Insulin), By Application (Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes), By Drug Classification (Branded Drugs, Generic Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online) And By Region, Opportunities And Strategies – Global Forecast To 2031 is one of a series of new reports from The Business Research Company that provides a insulin drugs market overview, forecast insulin drugs market size and growth for the whole market, insulin drugs market segments, geographies, insulin drugs market trends, insulin drugs market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request for a Sample of the Global Insulin Drugs Market Report https://www.thebusinessresearchcompany.com/sample.aspx?id=6280&type=smp

Not what you were looking for? Here is a list of similar reports by The Business Research Company:

Diabetes Care Devices Global Market Report 2022 – By Type (Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables) – Market Size, Trends, And Global Forecast 2022-2026 https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report

Smart Insulin Pens Global Market Report 2022 – By Type (First Generation Pens, Second Generation Pens (Bluetooth Enabled, USB Connected)), By End User (Hospitals & Clinics, Ambulatory Surgical Centres, Home Care Settings), By Usability (Prefilled, Reusable), By Application (Type 1 Diabetes, Type 2 Diabetes) – Market Size, Trends, And Global Forecast 2022-2026 https://www.thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report

Autoinjectors Global Market Report 2022 – By Type (Disposable Autoinjectors, Reusable Autoinjectors), By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis), By Route Of Administration (Subcutaneous, Intramuscular), By Distribution Channel (Online Retailer, Pharmacy), By End User (Home Care Settings, Hospitals And Clinics) – Market Size, Trends, And Global Forecast 2022-2026 https://www.thebusinessresearchcompany.com/report/autoinjectors-global-market-report

About The Business Research Company

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Call us now for personal assistance with your purchase: Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: info@tbrc.info

Check out our: LinkedIn: https://bit.ly/3b7850r Twitter: https://bit.ly/3b1rmjS YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Blog: http://blog.tbrc.info/

Oliver Guirdham The Business Research Company +44 20 7193 0708 info@tbrc.info Visit us on social media: Facebook Twitter LinkedIn

Market Research Products, Services, Solutions For Your Business - TBRC

EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone's Internet News Presswire™, tries to define some of the boundaries that are reasonable in today's world. Please see our Editorial Guidelines for more information.

© 1995-2022 Newsmatics Inc. dba EIN Presswire All Right Reserved.